RJA
PRVA icon

Raymond James & Associates’s Privia Health PRVA Stock Holding History

Raymond James & Associates’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,543
Closed -$458K – 3908
2023
Q2 		$458K Buy
17,543
+8,639
+97% +$228K ﹤0.01% 2996
2023
Q1 		$246K Buy
+8,904
New +$235K ﹤0.01% 3377
2022
Q4 		– Sell
-11,384
Closed -$388K – 4038
2022
Q3 		$388K Buy
+11,384
New +$421K ﹤0.01% 3015

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's PRVA Position: Q3 2023 in Review

Raymond James & Associates sold out of Privia Health (PRVA) in Q3 2023, closing a stake of 17,543 shares — an estimated $458K sold.

Raymond James & Associates first reported a position in PRVA in Q3 2022 and held it in 3 quarters. The position peaked at $458K in Q2 2023. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

  • Raymond James & Associates reported no remaining Privia Health position as of Q3 2023 after selling out during the quarter.
  • Raymond James & Associates sold 17,543 Privia Health shares in Q3 2023, an estimated $458K.
  • Raymond James & Associates first reported a position in Privia Health in Q3 2022 and held it in 3 quarters.
  • Raymond James & Associates's Privia Health position peaked at $458K in Q2 2023.
  • 218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.